← Back to Search

Indoor Air Quality Monitor for Smoking Cessation

N/A
Recruiting
Led By Jamie Ostroff, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult (aged >18 years) MSK patients as per the EHR
Be older than 18 years old
Must not have
N/A
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if using an indoor air quality monitor can help cancer patients in a smoking cessation program have a smoke-free home."

Who is the study for?
This trial is for cancer patients trying to quit smoking and are enrolled in MSK's Tobacco Treatment Program. It aims to see if using an air quality monitor helps them keep their homes smoke-free.
What is being tested?
The study is testing the effectiveness of the AirGradient ONE indoor air quality monitor in encouraging a smoke-free environment at home among participants.
What are the potential side effects?
Since this trial involves using an air quality monitor, there are no direct medical side effects associated with its use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of participants using the air quality monitoring device for 14 consecutive days
Percentage of participants who attend the study-specific smoke-free workshop sessions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MSK Participants who are current smokersExperimental Treatment1 Intervention
10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,977 Previous Clinical Trials
599,717 Total Patients Enrolled
Jamie Ostroff, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
17 Previous Clinical Trials
7,000 Total Patients Enrolled
~7 spots leftby Nov 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top